| Secondary |
| Drug Use For Unknown Indication |
45.2% |
| Product Used For Unknown Indication |
15.5% |
| Constipation |
8.4% |
| Essential Hypertension |
6.5% |
| Hypertension |
5.8% |
| Cardiac Disorder |
3.9% |
| Type 2 Diabetes Mellitus |
2.6% |
| Arrhythmia |
1.9% |
| Asthma |
1.9% |
| Depression |
1.9% |
| Hypokalaemia |
1.9% |
| Prophylaxis |
1.3% |
| Acne |
0.6% |
| Back Pain |
0.6% |
| Delusional Disorder, Persecutory Type |
0.6% |
| Extrapyramidal Disorder |
0.6% |
| Venous Insufficiency |
0.6% |
|
| Hyperkalaemia |
16.0% |
| Transaminases Increased |
16.0% |
| Somnolence |
12.0% |
| Agranulocytosis |
8.0% |
| Fall |
8.0% |
| Renal Failure |
8.0% |
| Rib Fracture |
8.0% |
| Haemothorax |
4.0% |
| Hypophosphataemia |
4.0% |
| Pancreatitis Acute |
4.0% |
| Prescribed Overdose |
4.0% |
| Tachycardia |
4.0% |
| Thirst |
4.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.5% |
| Product Used For Unknown Indication |
22.1% |
| Constipation |
5.9% |
| Hypertension |
5.8% |
| Colorectal Cancer Metastatic |
3.8% |
| Infection |
3.5% |
| Abdominal Pain |
3.0% |
| Depression |
3.0% |
| Premedication |
2.7% |
| Non-small Cell Lung Cancer |
2.4% |
| Prophylaxis |
2.3% |
| Therapeutic Embolisation |
2.3% |
| Epilepsy |
2.1% |
| Ill-defined Disorder |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Anxiety |
1.8% |
| Diarrhoea |
1.8% |
| Mixed Connective Tissue Disease |
1.8% |
| Hepatic Neoplasm Malignant |
1.5% |
| Hypokalaemia |
1.5% |
|
| Electrocardiogram Qt Prolonged |
8.9% |
| Renal Failure Acute |
8.9% |
| Vomiting |
7.6% |
| Lung Disorder |
6.3% |
| Pleural Effusion |
6.3% |
| Thrombocytopenia |
6.3% |
| Loss Of Consciousness |
5.1% |
| Neutropenia |
5.1% |
| Pruritus |
5.1% |
| White Blood Cell Count Increased |
5.1% |
| Acute Myeloid Leukaemia |
3.8% |
| Agranulocytosis |
3.8% |
| International Normalised Ratio Increased |
3.8% |
| Oesophagitis |
3.8% |
| Overdose |
3.8% |
| Pain |
3.8% |
| Respiratory Distress |
3.8% |
| Sinus Bradycardia |
3.8% |
| Acute Generalised Exanthematous Pustulosis |
2.5% |
| Convulsion |
2.5% |
|
